SHINE for Autumn Act of 2023
The source supplies the latest action, but no lifecycle stage.
Latest action (12 Jun 2024): Ordered to be Reported by the Yeas and Nays: 45 - 0.
What this bill does
H.R. 5012, the SHINE for Autumn Act of 2023, aims to improve research and data collection on stillbirths. It would authorize the Department of Health and Human Services to award grants to states for stillbirth surveillance, data collection on risk factors, and building public health capacity, with $5 million annually authorized for fiscal years 2024–2028. It also directs HHS to issue guidelines to state health departments and vital statistics units on stillbirth data collection and to develop public educational materials, authorizing $1 million annually for the same period. Additionally, the bill establishes support for perinatal pathology and postdoctoral research fellowships focused on stillbirth causes, authorizing $3 million annually through 2028.
The bill primarily affects state and local public health agencies, vital statistics offices, health care providers, and researchers involved in maternal and fetal health. It also touches families who have experienced stillbirth, since data collection provisions require their consent and privacy protections. HHS would consult with medical associations, bereavement organizations, and individuals with lived experience in developing guidelines and materials. The bill also requires HHS to report to Congress within five years on the guidelines issued and on the progress of the fellowship programs.
The bill was introduced in July 2023 by Rep. Young Kim and referred to the House Committee on Energy and Commerce. It was ordered to be reported by that committee on June 12, 2024, by a vote of 45–0. As of the latest action, it has not received a floor vote in the House, and would need to pass both chambers and be signed by the President to become law.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Official summary
Stillbirth Health Improvement and Education for Autumn Act of 2023 or the SHINE for Autumn Act of 2023
This bill authorizes grants and establishes other programs to improve data collection on stillbirths.
Specifically, the Department of Health and Human Services (HHS) may award grants for surveillance and data collection on stillbirths, and HHS must issue guidelines for health departments and vital statistics units concerning the collection of stillbirth data. HHS must also develop educational awareness materials about stillbirths and make them publicly available.
Furthermore, HHS must implement a fellowship program to provide training in perinatal autopsy pathology and otherwise support research on stillbirths and fetal autopsies.
The bill also requires HHS to issue a report with educational guidelines on stillbirths and stillbirth risk factors.
Timeline
12 Jun 2024
Ordered to be Reported by the Yeas and Nays: 45 - 0.
Common questions
- What does H.R. 5012 do?
- H.R. 5012, the SHINE for Autumn Act of 2023, aims to improve research and data collection on stillbirths. It would authorize the Department of Health and Human Services to award grants to states for stillbirth surveillance, data collection on risk factors, and building public health capacity, with $5 million annually authorized for fiscal years 2024–2028. It also directs HHS to issue guidelines to state health departments and vital statistics units on stillbirth data collection and to develop public educational materials, authorizing $1 million annually for the same period. Additionally, the bill establishes support for perinatal pathology and postdoctoral research fellowships focused on stillbirth causes, authorizing $3 million annually through 2028. The bill primarily affects state and local public health agencies, vital statistics offices, health care providers, and researchers involved in maternal and fetal health. It also touches families who have experienced stillbirth, since data collection provisions require their consent and privacy protections. HHS would consult with medical associations, bereavement organizations, and individuals with lived experience in developing guidelines and materials. The bill also requires HHS to report to Congress within five years on the guidelines issued and on the progress of the fellowship programs. The bill was introduced in July 2023 by Rep. Young Kim and referred to the House Committee on Energy and Commerce. It was ordered to be reported by that committee on June 12, 2024, by a vote of 45–0. As of the latest action, it has not received a floor vote in the House, and would need to pass both chambers and be signed by the President to become law.
- Has H.R. 5012 become law?
- The source does not supply a confirmed lifecycle stage for H.R. 5012. Check the latest action and official source below.
- Who sponsored H.R. 5012?
- H.R. 5012 was sponsored by Rep. Kim, Young [R-CA-40] (R-CA), with 114 cosponsors.
- What's the latest action on H.R. 5012?
- Ordered to be Reported by the Yeas and Nays: 45 - 0. (12 Jun 2024).
Related bills in Health
Choices for Increased Mobility Act of 2026
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
Access to Medical Supplies Act
Lower Premiums, Faster Payments Act
More bills from Rep. Kim, Young [R-CA-40]
Expressing support for the recognition of October 5th as "National Peroxisomal Disorder Awareness Day".
Amending the Rules of the House of Representatives with respect to the certification requirement in the case of a congressional earmark or limited tax or tariff benefit.
North Korean FAKER Act
STRATA Act of 2026
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.